NEJM This Week

This episode covers trials showing mucoactive agents harm ICU patients and azithromycin fails for preschool wheezing, while sunvozertinib and cervodotide show promise for lung cancer and obesity.

This NEJM This Week episode covers trials on secukinumab for polymyalgia rheumatica, base editing for hypercholesterolemia, selpercatinib for lung cancer, and talquetamab for myeloma.

This episode covers trials on finerenone for chronic kidney disease, apalutamide for high-risk prostate cancer, and sirolimus-coated balloons for peripheral artery disease.

This episode highlights advances in treating prostate cancer, multiple myeloma, acute pain, and IgA nephropathy, alongside a review of platelet factor 4 disorders and a case of mucosal leishmaniasis.

This episode covers major advances in pancreatic and bladder cancer treatments, including Diraxon RASIB and Enfortumab-vidotin-pembrolizumab.